GlassScriptPhysician profile
Calvin Lewis
NPI 1841731130
$3,426.74
in general payments reported to CMS, 2019-2025
13 companies · $2,816 in 2025
The $2,816 reported for 2025 was more than what 92% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $192 · 2024: $419 · 2025: $2,816.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,277 · Travel and Lodging: $1,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,276.88 |
| Travel and Lodging | $1,149.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,350.37 | 2025 | |
| Teleflex LLC | $1,052.02 | 2024-2025 | Barrigel, Urolift |
| Abbvie INC. | $165.08 | 2023 | |
| Telix Pharmaceuticals | $161.72 | 2025 | Illuccix |
| Janssen Biotech, INC. | $145.07 | 2024 | Rybrevant |
| Bayer Healthcare Pharmaceuticals INC. | $139.37 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $121.30 | 2023-2025 | Orgovyx |
| Boston Scientific Corporation | $75.38 | 2024-2025 | Spaceoar Vue System - 10ml |
| Pfizer INC. | $63.96 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $62.08 | 2025 | |
| Siemens Medical Solutions USA, INC. | $59.04 | 2025 | Truebeam, Biograph Trinion Ep Ct64 |
| Bioprotect Medical, INC. | $16.87 | 2025 | Bioprotect Balloon Implant System |
| Myriad Genetic Laboratories, INC. | $14.48 | 2024 | Prolaris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Calvin Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.